April Killikelly - Concepedia

Author

April Killikelly

Also Known As

A Killikelly, A. Killikelly, Angela Sinilaite, April Killikelly, April M. Killikelly, Comité consultatif national de l’immunisation (CCNI)

Publications

833

Citations

H-Index

Concepts

All Affiliations

Public Health Agency of Canada McGill University University of Alberta University of Ottawa Stollery Children's Hospital

About

April Killikelly is an author at Public Health Agency of Canada specializing in medicine, virology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	173
2	Natural Sciences	1	1	27
3	Biochemistry	1	1	27
4	Immunology	1	1	146
5	Microbiology	1	1	27

April Killikelly

Publications

792

Citations

H-Index

Page 1

	Year	Citations
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera Joan O. Ngwuta, Man Chen, Kayvon Modjarrad, Science Translational Medicine	2015	417
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus April Killikelly, Masaru Kanekiyo, Barney S. Graham Scientific Reports VaccinationVirus StructureViral ReplicationVaccine DevelopmentMedicine	2016	146
Structural Basis of Cyclophilin B Binding by the Calnexin/Calreticulin P-domain Guennadi Kozlov, Sara Bastos‐Aristizabal, Pekka Määttänen, Journal of Biological Chemistry	2010	97
Structure-Based Functional Characterization of Repressor of Toxin (Rot), a Central Regulator of Staphylococcus aureus Virulence April Killikelly, Meredith A. Benson, Elizabeth A. Ohneck, Journal of Bacteriology Crystal StructureToxinologyStructural BioinformaticsBacteriologyStaphylococcus Aureus	2014	27
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants Gebremedhin Beedemariam Gebretekle, Man Wah Yeung, Raphael Ximenes, Vaccine	2024	23
Thermodynamic Signatures of the Antigen Binding Site of mAb 447–52D Targeting the Third Variable Region of HIV-1 gp120 April Killikelly, Hui-Tang Zhang, Brett Spurrier, Biochemistry	2013	21
Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada April Killikelly, Matthew Tunis, Althea House, Canada Communicable Disease Report	2020	18
Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants Dorothy Moore, Angela Sinilaité, April Killikelly Canada Communicable Disease Report	2022	17
Burden of disease of RSV in infants, children and pregnant women and people Elissa M. Abrams, Paméla Doyon-Plourde, Phaedra Davis, Canada Communicable Disease Report	2024	14
Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat April Killikelly, Amanda Shane, Man Wah Yeung, Canada Communicable Disease Report	2020	12

Page 1